Antibody Drug Gives New Life To Chronic Fatigue Sufferers
A Phase II test make an anti - cancer drug to sufferers of chronic fatigue syndrome ( CFS ) has produced encouraging , if puzzling , resultant . Two - third of the patient in the small trial evidence dramatic but delay response , while one - third gained picayune welfare from the treatment . CFS is a particularly hard term to diagnose , let alone process . Having once been brush aside as psychosomatic , there is nowmedical acceptancethat it has a biologic cause , but not much agreement on what that is ....